Komori
General Meetings of Shareholders4503Astellas Pharma Inc.Pharmaceuticals

Notice of Convocation of the 21st Annual General Meeting of Shareholders (Matters Subject to Electronic Provision)

At the 21st Annual General Meeting of Shareholders, the company is proposing the election of 7 Directors (excluding Directors who are Audit and Supervisory Committee Members) and 3 Directors who are Audit and Supervisory Committee Members. The candidates for Directors who are Audit and Supervisory Committee Members include 1 new outside director.

Worth reading
53Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
10
Number of proposals (number of candidates for election)
Wording
Definitive
How definitive the wording is.

Resolutions for the General Meeting of Shareholders

Annual (21st fiscal year)
2026
Jun 19
Date and time23 days from this disclosure to the meeting
Matters for resolution2 items
  1. Election of 7 directors (excluding directors who are Audit and Supervisory Committee Members)

  2. Election of 3 directors who are Audit and Supervisory Committee members

Shareholder Proposal

Not disclosed

A shareholder proposal is a resolution submitted by a shareholder, rather than by the company.
Director nominee
10Nominees
1New
7Outside
Resolutions for the General Meeting of Shareholders
ItemDetails
Type of shareholders' meetingAnnual (21st fiscal year)
Date and time10:00 a.m. on Friday, 19 June 2026
Matters for resolutionProposal No. 1: Election of 7 directors (excluding directors who are Audit and Supervisory Committee Members), Proposal No. 2: Election of 3 directors who are Audit and Supervisory Committee members
Shareholder ProposalNot disclosed
Director nominee10 director candidates (1 new, 7 outside directors)
Items this document does not state (1)
Percentage voting in favor

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The company explains that it is requesting the election of these candidates because their extensive experience, specialized knowledge and broad perspectives are needed or expected to be reflected in the management, oversight and audits of the company.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice of Convocation of the 21st Annual General Meeting of Shareholders (Matters Subject to Electronic Provision) | Astellas Pharma Inc. (4503) timely disclosure | Komori